ADRIANA GONZALEZ: Open Payments
NPI 1003250796 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,880 in 168 payments from 27 companies in 2025. Trend: 2023 $523 · 2024 $2,599 · 2025 $2,880
Food & beverage: $2,880
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 21 | $465 |
| Bayer Healthcare Pharmaceuticals Inc. | 21 | $245 |
| Insulet Corporation | 19 | $241 |
| Amgen Inc. | 18 | $226 |
| Corcept Therapeutics | 11 | $174 |
| Radius Health, Inc. | 14 | $173 |
| Ascendis Pharma Endocrinology Inc | 7 | $172 |
| Lilly USA, LLC | 12 | $162 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $144 |
| Novo Nordisk Inc | 6 | $123 |
Products named: Dexcom G6 Transmitter, Kerendia, Omnipod, Korlym, Tymlos, Yorvipath, ISTURISA, TEPEZZA.
Industry payments across TX — which companies pay providers there.
